Blocking cytidine deaminase supported degradation of the DNMT1 protein in cancer cell lines (range 82–90%, Fig. 8), even though decitabine treatment alone of cancer cells caused a small but significant increase in DNMT1 mRNA expression (Fig. 7B). Here, DNMT1 is linked to cancer.